B+
Bull case
25%
Probability
Target price
$4.30
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
ABOS
AcumenFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
A positive ALTITUDE-AD signal could materially re-rate the stock because the late-2026 readout is the principal value inflection, while the reported cash position limits immediate financing pressure. EBD provides additional longer-dated optionality, but remains early-stage.
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Binary or delayed ALTITUDE-AD results could cause substantial downside [#PR-EARNINGS-2026-05-13].
Momentum
72
Value
41
Sentiment
28
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.95 · Bull $4.30 · Bear $0.90Analysis 2026-08-03; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-08 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-08
Investment thesis
As of 2026-09-08
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-08. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $7.40
Why
Momentum72 · Δ7d -
Value41 · Δ7d -0.0
Sentiment28 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • Binary or delayed ALTITUDE-AD results could cause substantial downside [#PR-EARNINGS-2026-05-13].
- • Competition in Alzheimer’s disease therapies may limit differentiation and commercial opportunity [#PR-EARNINGS-2026-05-13].
- • The trial is low-powered and a weak or delayed readout could sharply impair the thesis.
Catalyst clock
2026-10-24
ALTITUDE-AD Phase 2 topline readout
Lead driver: Sentiment · See AI snapshot
Momentum
72
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
28
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 72.3 / Value 41.2 / Sentiment 27.8
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-03. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$1.95
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.90
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$192.36M
Beta
0.24
Shares Out
72.32M
P/E (TTM) · Derived
-1.3
P/S (TTM)
-
P/FCF (TTM) · Derived
-1.83
Rev YoY
-100.0%
EPS YoY
-33.0%
Gross Margin
-
Op Margin
-
Net Debt
-$85.55M
Current Ratio
2.47
As of 2026-09-08 • Updated nightlySource: Internal modelMethods & Data